Αποτελέσματα Αναζήτησης
Vitamin D was the most prevalent supplement: 191 women taking either tamoxifen or an AI reported taking vitamin D. The majority of interactions involved herbal preparations (89% versus 11% involving vitamins).
14 Οκτ 2014 · Many of our patients ask about supplements or medications for hair loss during and after treatment. Some have anectdotally reported good results with either biotin or a hair/skin/nail...
10 Μαΐ 2016 · Endocrine therapy-induced hair loss (ETIHL) associated with aromatase inhibitors and tamoxifen treatment is currently mostly reported but remained an unresolved therapeutic issue in patients with breast cancer (BC) since the number of studies regarding the management is limited in literature.
Advanced practitioners are in a position to prescribe tamoxifen, review medication interactions, educate patients, impact patients’ quality of life, improve patients’ sense of control, and increase patients’ partnerships with their oncology providers.
26 Φεβ 2024 · Hair loss/thinning is a common side effect of tamoxifen in estrogen receptor (ER) positive breast cancer therapy. Some nutraceuticals known to promote hair growth are avoided during breast cancer therapy for fear of phytoestrogenic activity.
30 Μαΐ 2017 · Background: Hair loss and thinning have been reported by breast cancer patients treated with aromatase inhibitors (AIs); these side effects are documented to be reasons that patients discontinue their AI therapy and have been shown to be associated with a decrease in quality of life.
16 Μαΐ 2018 · We reviewed clinically significant hair-related disorders, underlying pathophysical mechanisms, severity grading scales, patient-reported quality-of-life instruments, management strategies, and future translational research opportunities.
